VIVO Ventures VI Affiilates Fund, L.P., 10% Owner at Sagent Pharmaceuticals, Inc. (SGNT), sold 2,316 shares at $13.55 ($31K) on 2016-04-21, disclosed to the SEC on 2016-09-01.
Open-market sale of $31k SGNT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.55 | 17 | $230 | 0.7% |
| 2 | $13.55 | 2,299 | $31K | 99.3% |
| Total | $13.55 avg | 2,316 | $31K | 100% |